Evan Brody, DPM
Podiatrist · Kennesaw, GANPI 1679548168
Payments from drug & device makers
Across 23 payments — averaging $20.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Osteomed LLC$80
- Stryker$70
- Smith+Nephew$46
- Organogenesis Inc.$42
- Amgen$36
- Triad Life Sciences Inc.$28
- plus $175 from 9 others
What the payments were for
- Food & beverage$39783%
- Education$8017%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Osteomed LLC | 1 | $80 |
| Stryker(2 entities) | 5 | $70 |
| Smith+Nephew | 2 | $46 |
| Organogenesis Inc. | 2 | $42 |
| Amgen(2 entities) | 2 | $36 |
| Triad Life Sciences Inc. | 1 | $28 |
| Merck | 2 | $28 |
| Arthrosurface Incorporated | 1 | $25 |
| Celularity Inc. | 1 | $24 |
| Kerecis Limited | 1 | $23 |
| Integra Lifesciences Corporation | 1 | $22 |
| Zimmer Biomet | 1 | $16 |
| Zyla Life Sciences, Inc. | 1 | $15 |
| Orthofix Medical, Inc. | 1 | $13 |
| Paragon 28, Inc. | 1 | $8 |
How this compares
$478 in reported general payments places this provider in the 35th percentile of 177 podiatrist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 107 | $1,904 |
| Gabapentin | 22 | $486 |
| Itraconazole | 11 | $467 |
| Pregabalin | 11 | $460 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 30 | $322 |
| Terbinafine Hcl | 97 | $299 |
| Levofloxacin | 48 | $230 |
| Methylprednisolone | 34 | $213 |
| Doxycycline Monohydrate | 11 | $141 |
| Allopurinol | 15 | $140 |
| Cyclobenzaprine Hcl | 13 | $77 |
| Ibuprofen | 13 | $50 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Kennesaw
- Sadia AliKennesaw$3K
- Allen RaphaelSmyrna$336K
- Ira KrausFort Oglethorpe$247K
- Janaki NadarajahMartinez$208K
- Stephen BarrettMarietta$82K
- Mohammad SharifAtlanta$79K
- Craig CamastaAtlanta$49K
- Ryan FitzgeraldCanton$43K
- Margo JimenezAtlanta$19K
- Samantha MinerSmyrna$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.